SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-028403
Filing Date
2017-05-01
Accepted
2017-05-01 16:09:07
Documents
5
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A a17-2135_3defa14a.htm DEFA14A 6882
2 GRAPHIC g21353bii001.gif GRAPHIC 67677
3 GRAPHIC g21353bii002.gif GRAPHIC 105341
4 GRAPHIC g21353bii003.gif GRAPHIC 21781
5 GRAPHIC g21353bii004.gif GRAPHIC 4573
  Complete submission text file 0001104659-17-028403.txt   282906
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36562 | Film No.: 17800813
SIC: 2834 Pharmaceutical Preparations